Buch, Englisch, 578 Seiten, Previously published in hardcover, Format (B × H): 155 mm x 235 mm, Gewicht: 9844 g
Diagnosis and Management
Buch, Englisch, 578 Seiten, Previously published in hardcover, Format (B × H): 155 mm x 235 mm, Gewicht: 9844 g
ISBN: 978-3-662-52359-9
Verlag: Springer
This book is a timely textbook that covers all aspects of neuroendocrine tumors (NET) from epidemiology, pathological classification and evaluation and molecular biology through to diagnostic imaging methods and therapeutic options, including the latest targeted therapies. The various types of NET are individually discussed, including carcinoid tumors, insulinomas, gastrinomas, glucagonomas, VIPomas, somatostatinomas, PPomas, medullary thyroid carcinomas, adrenocortical cancer, pheochromocytomas, paragangliomas and non-functioning pancreatic NETs. The contributing authors are internationally recognized experts who bring a wealth of experience to the subject. This book will be an invaluable source of information for practicing medical oncologists, surgeons, endocrinologists, gastroenterologists and pathologists and also trainees.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Chirurgie Neurochirurgie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Endokrinologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
Weitere Infos & Material
Introduction.- Historical Background.- Epidemiology.- Pathological Classification.- Carcinoid Syndrome.- Molecular Biology.- Insulinoma.- Gastrinoma.- Vipoma.- Glucagonoma.- Pathological Evaluation.- Radiological Imaging.- Nuclear Imaging.- Genetic Syndromes Associated with NET.- Surgical Approach.- Locoregional treatment (RFA).- Embolization (Chemo/radio).- PRRT.- Management of Hormonal symptoms.- Chemotherapy.- Somatostatin Analogues.- Targeted Therapies.- Guidelines.- Societies and Guidelines.- Biomarkers.- Medullary Thyroid Cancer.- Adrenocortical Cancer.- Paraganglioma, feokromositoma.- Nonfonksiyone pNET.- Somatostatinoma.- Poorly differentiated NET.- Management of MEN.- Ppoma.
